S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

BRNS Barinthus Biotherapeutics PLC

0.9999

0.0499 (5.25%)

Jan 30 2025 - Closed

Delayed by 15 minutes

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

Barinthus Biotherapeutics (NASDAQ:BRNS)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Barinthus Biotherapeutics Charts.

Barinthus Biotherapeutics (NASDAQ:BRNS)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Barinthus Biotherapeutics Charts.

Barinthus Biotherapeutics PLC News

Form 8-K - Current report
Friday 10 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
Tuesday 31 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Friday 20 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 25 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 6 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 November 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Tuesday 15 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 5 September 2024 (5 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 8 August 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 18 June 2024 (7 months ago) • Edgar (US Regulatory)

More Barinthus Biotherapeutics PLC News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions